Andrea Mabilia

868 citations
16 papers · 567 indexed · h-index 12

Andrea Mabilia

15 papers receiving 557 citations

Peers

Andrea Mabilia
Comparison fields: 5 of 55
  • Oncology 330
  • Gastroenterology 45
  • Pulmonary and Respiratory Medicine 252
  • Cancer Research 80
  • Hepatology 42
Replace A Auricchio with:
A Auricchio Italy
Sunao Uemura Japan
Chung‐Rong Changchien Taiwan
Kozo Miyatani Japan
Keun Wook Lee South Korea
Yu Ohkura Japan
Yasunari Kawabata Japan
Tomotaka Saito Japan
Haruyuki Kawai Japan
Andrea Mabilia relative to A Auricchio Italy A Auricchio's profile →
Citations per field
00.5×1.5×
A Auricchio · 1×
Citations per year

Countries citing papers authored by Andrea Mabilia

Since Specialization
Citations

This map shows the geographic impact of Andrea Mabilia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Mabilia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Mabilia more than expected).

Fields of papers citing papers by Andrea Mabilia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Mabilia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Mabilia. The network helps show where Andrea Mabilia may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andrea Mabilia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrea Mabilia Line = papers co-authored together Andrea Mabilia links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 20240
2 20237
3 20222
4 20224
5
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score.
201925
6 201834
7 201747
8 201715
9 2017167
10 201733
11 201421
12 201449
13 201345
14 201386
15 201311
16 201221

About Andrea Mabilia

Andrea Mabilia is a scholar working on Cancer Research, Oncology and Hepatology, having authored 16 papers that have together received 567 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), Metastasis and carcinoma case studies (3 papers), Cancer, Lipids, and Metabolism (3 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Intestinal and Peritoneal Adhesions (2 papers), Colorectal Cancer Surgical Treatments (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Oncology (330 citations), Gastroenterology (45 citations) and Pulmonary and Respiratory Medicine (252 citations). Andrea Mabilia has collaborated with scholars based in Italy, Morocco and France. Frequent co-authors include A Auricchio, Eva Lieto, Michele Orditura, Gennaro Galizia, Paolo Castellano, Francesca Cardella, Ferdinando De Vita, Vincenzo Napolitano, Anna Zamboli and Francesca Ferraraccio. Their work appears in journals such as PLoS ONE, Diseases of the Colon & Rectum and World Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026